SEC
PCYC

Seven Eight Capital’s PHARMACYCLICS INC PCYC Stock Holding History

Seven Eight Capital’s Portfolio PCYC Stock Details PCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-200
Closed -$18K – 775
2014
Q2 		$18K Buy
+200
New +$18.8K 0.02% 448

Other funds holding PCYC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Seven Eight Capital's PCYC Position: Q3 2014 in Review

Seven Eight Capital sold out of PHARMACYCLICS INC (PCYC) in Q3 2014, closing a stake of 200 shares — an estimated $18K sold.

Seven Eight Capital first reported a position in PCYC in Q2 2014 and held it in 1 quarter. The position peaked at $18K in Q2 2014. 250 funds tracked by Wall St. Rank hold PCYC as of Q3 2014.

  • Seven Eight Capital reported no remaining PHARMACYCLICS INC position as of Q3 2014 after selling out during the quarter.
  • Seven Eight Capital sold 200 PHARMACYCLICS INC shares in Q3 2014, an estimated $18K.
  • Seven Eight Capital first reported a position in PHARMACYCLICS INC in Q2 2014 and held it in 1 quarter.
  • Seven Eight Capital's PHARMACYCLICS INC position peaked at $18K in Q2 2014.
  • 250 funds tracked by Wall St. Rank held PHARMACYCLICS INC as of Q3 2014.

Based on Seven Eight Capital's 13F filing for Q3 2014, filed 13 Nov 2014.